FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367668756> ?p ?o ?g. }

• W4367668756 endingPage "1460" @default.
• W4367668756 startingPage "1460" @default.
• W4367668756 abstract "Implantation failure remains a critical barrier to in vitro fertilization. Prednisone, as an immune-regulatory agent, is widely used to improve the probability of implantation and pregnancy, although the evidence for efficacy is inadequate.To determine the efficacy of 10 mg of prednisone compared with placebo on live birth among women with recurrent implantation failure.A double-blind, placebo-controlled, randomized clinical trial conducted at 8 fertility centers in China. Eligible women who had a history of 2 or more unsuccessful embryo transfer cycles, were younger than 38 years when oocytes were retrieved, and were planning to undergo frozen-thawed embryo transfer with the availability of good-quality embryos were enrolled from November 2018 to August 2020 (final follow-up August 2021).Participants were randomized (1:1) to receive oral pills containing either 10 mg of prednisone (n = 357) or matching placebo (n = 358) once daily, from the day at which they started endometrial preparation for frozen-thawed embryo transfer through early pregnancy.The primary outcome was live birth, defined as the delivery of any number of neonates born at 28 or more weeks' gestation with signs of life.Among 715 women randomized (mean age, 32 years), 714 (99.9%) had data available on live birth outcomes and were included in the primary analysis. Live birth occurred among 37.8% of women (135 of 357) in the prednisone group vs 38.8% of women (139 of 358) in the placebo group (absolute difference, -1.0% [95% CI, -8.1% to 6.1%]; relative ratio [RR], 0.97 [95% CI, 0.81 to 1.17]; P = .78). The rates of biochemical pregnancy loss were 17.3% in the prednisone group and 9.9% in the placebo group (absolute difference, 7.5% [95% CI, 0.6% to 14.3%]; RR, 1.75 [95% CI, 1.03 to 2.99]; P = .04). Of those in the prednisone group, preterm delivery occurred among 11.8% and of those in the placebo group, 5.5% of pregnancies (absolute difference, 6.3% [95% CI, 0.2% to 12.4%]; RR, 2.14 [95% CI, 1.00 to 4.58]; P = .04). There were no statistically significant between-group differences in the rates of biochemical pregnancy, clinical pregnancy, implantation, neonatal complications, congenital anomalies, other adverse events, or mean birthweights.Among patients with recurrent implantation failure, treatment with prednisone did not improve live birth rate compared with placebo. Data suggested that the use of prednisone may increase the risk of preterm delivery and biochemical pregnancy loss. Our results challenge the value of prednisone use in clinical practice for the treatment of recurrent implantation failure.Chinese Clinical Trial Registry Identifier: ChiCTR1800018783." @default.
• W4367668756 created "2023-05-03" @default.
• W4367668756 creator A5011278327 @default.
• W4367668756 creator A5011697557 @default.
• W4367668756 creator A5011877804 @default.
• W4367668756 creator A5013058348 @default.
• W4367668756 creator A5022380345 @default.
• W4367668756 creator A5028603894 @default.
• W4367668756 creator A5029135809 @default.
• W4367668756 creator A5033207412 @default.
• W4367668756 creator A5034251280 @default.
• W4367668756 creator A5034442173 @default.
• W4367668756 creator A5037074212 @default.
• W4367668756 creator A5037677450 @default.
• W4367668756 creator A5038137713 @default.
• W4367668756 creator A5039074091 @default.
• W4367668756 creator A5039649645 @default.
• W4367668756 creator A5047157625 @default.
• W4367668756 creator A5053855584 @default.
• W4367668756 creator A5058605138 @default.
• W4367668756 creator A5059958350 @default.
• W4367668756 creator A5061015930 @default.
• W4367668756 creator A5061316406 @default.
• W4367668756 creator A5068297054 @default.
• W4367668756 creator A5068954598 @default.
• W4367668756 creator A5072797355 @default.
• W4367668756 creator A5073501391 @default.
• W4367668756 creator A5073957485 @default.
• W4367668756 creator A5075817604 @default.
• W4367668756 creator A5078856013 @default.
• W4367668756 creator A5082861002 @default.
• W4367668756 creator A5086459592 @default.
• W4367668756 date "2023-05-02" @default.
• W4367668756 modified "2023-09-30" @default.
• W4367668756 title "Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization" @default.
• W4367668756 cites W1488278893 @default.
• W4367668756 cites W1944626957 @default.
• W4367668756 cites W1989564158 @default.
• W4367668756 cites W2030721218 @default.
• W4367668756 cites W2162431335 @default.
• W4367668756 cites W2193892683 @default.
• W4367668756 cites W2320143189 @default.
• W4367668756 cites W2345078291 @default.
• W4367668756 cites W2520214880 @default.
• W4367668756 cites W2529757628 @default.
• W4367668756 cites W2592467161 @default.
• W4367668756 cites W2612020810 @default.
• W4367668756 cites W2759681986 @default.
• W4367668756 cites W2794165626 @default.
• W4367668756 cites W2801284960 @default.
• W4367668756 cites W2886704150 @default.
• W4367668756 cites W2903206197 @default.
• W4367668756 cites W2904591288 @default.
• W4367668756 cites W2916530067 @default.
• W4367668756 cites W2916540196 @default.
• W4367668756 cites W2978015549 @default.
• W4367668756 cites W3004948551 @default.
• W4367668756 cites W3008357787 @default.
• W4367668756 cites W3048758697 @default.
• W4367668756 cites W3049730681 @default.
• W4367668756 cites W3064314015 @default.
• W4367668756 cites W3100377772 @default.
• W4367668756 cites W3116730960 @default.
• W4367668756 cites W3138268479 @default.
• W4367668756 cites W3144321009 @default.
• W4367668756 cites W3196492713 @default.
• W4367668756 cites W3216216259 @default.
• W4367668756 cites W4225983712 @default.
• W4367668756 cites W4238586352 @default.
• W4367668756 cites W4283727084 @default.
• W4367668756 cites W4293107258 @default.
• W4367668756 cites W4311649077 @default.
• W4367668756 doi "https://doi.org/10.1001/jama.2023.5302" @default.
• W4367668756 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37129654" @default.
• W4367668756 hasPublicationYear "2023" @default.
• W4367668756 type Work @default.
• W4367668756 citedByCount "5" @default.
• W4367668756 countsByYear W43676687562023 @default.
• W4367668756 crossrefType "journal-article" @default.
• W4367668756 hasAuthorship W4367668756A5011278327 @default.
• W4367668756 hasAuthorship W4367668756A5011697557 @default.
• W4367668756 hasAuthorship W4367668756A5011877804 @default.
• W4367668756 hasAuthorship W4367668756A5013058348 @default.
• W4367668756 hasAuthorship W4367668756A5022380345 @default.
• W4367668756 hasAuthorship W4367668756A5028603894 @default.
• W4367668756 hasAuthorship W4367668756A5029135809 @default.
• W4367668756 hasAuthorship W4367668756A5033207412 @default.
• W4367668756 hasAuthorship W4367668756A5034251280 @default.
• W4367668756 hasAuthorship W4367668756A5034442173 @default.
• W4367668756 hasAuthorship W4367668756A5037074212 @default.
• W4367668756 hasAuthorship W4367668756A5037677450 @default.
• W4367668756 hasAuthorship W4367668756A5038137713 @default.
• W4367668756 hasAuthorship W4367668756A5039074091 @default.
• W4367668756 hasAuthorship W4367668756A5039649645 @default.
• W4367668756 hasAuthorship W4367668756A5047157625 @default.
• W4367668756 hasAuthorship W4367668756A5053855584 @default.
• W4367668756 hasAuthorship W4367668756A5058605138 @default.
• W4367668756 hasAuthorship W4367668756A5059958350 @default.

• next